Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: True, the news hit hard last month that the so-called “Boston patients” - two men who received bone marrow transplants that appeared to rid them completely of the AIDS-causing virus - had relapsed and gone back onto antiretroviral treatment. But experts say the disappointment could lay the basis for important leaps forward in the search for a cure. “It’s a setback for the patients, of course, but an advance for the field because the field has now gained a lot more knowledge,” said Steven Deeks, a professor and HIV expert at the University of California, San Francisco. He and other experts say the primary practical message is that current tests designed to detect even very low levels of HIV present in the body are simply not sensitive enough. As well as having the human immunodeficiency virus (HIV), the Boston patients both also had a type of blood cancer called lymphoma, for which they were treated using bone marrow transplants - one man in 2008 and the other in 2010. They continued taking the antiretroviral AIDS drugs, but eight months after each patient’s transplant, doctors found they could not detect any sign of HIV in their blood. In the early part of 2013, both patients decided to stop taking their AIDS drugs and both appeared to remain HIV-free - prompting their doctors, Timothy Henrich and Daniel Kuritzkes from Boston’s Brigham and Women’s Hospital, to announce at a conference in July that they may have been cured. Yet in December came news that one of the men had begun to show signs of an HIV rebound by August, while the second patient had a relapse in November. Henrich said the virus’ comeback underlined how ingenious HIV can be in finding hiding places in the body to evade attack efforts by the immune system and by drug treatment. “Through this research we have discovered the HIV reservoir is deeper and more persistent than previously known and that our current standards of probing for HIV may not be sufficient,” he said, adding that both patients were “currently in good health” and back on antiretroviral therapy. Barely a decade ago, few HIV scientists would have dared put the words HIV and cure in the same sentence. Yet some intriguing and inspiring cases in recent years mean many now believe it is just a question of time before a cure is found. First was the now famous case of Timothy Ray Brown, the so-called “Berlin patient,” whose HIV was eradicated by a complex treatment for leukemia in 2007 involving the destruction of his immune system and a stem cell transplant from a donor with a rare genetic mutation that resists HIV infection. Such an elaborate, expensive and life-threatening procedure could never be used as a broad-spectrum approach for the world’s 34 million HIV patients. But the results in Brown focused scientific attention on a genetic mutation known as ‘CCR5 delta 32’ as a target for possible gene therapy treatment. Then last March, French scientists who followed 14 HIV-positive people known as the “Visconti patients”, who were treated very swiftly with HIV drugs but then stopped treatment, said that even after seven years off therapy, they were still showing no signs of the virus rebounding. That announcement came only weeks after news of the “functional cure” of an HIV-positive baby in Mississippi who received antiretroviral treatment for 18 months from the day she was born. By the time she was two this appeared to have stopped the virus replicating and spreading. A “functional cure” is when HIV is reduced to such low levels that it is kept at bay even without treatment, though the virus can still be detected in the body. Sharon Lewin, an HIV expert at Monash University in Australia, said all these developments, as well as the setback suffered by the Boston patients, inspired scientists to investigate many different approaches in the search for a cure. “We’ve learnt many things here - and one of the most important is that a tiny, tiny amount of virus can get the whole thing going again,” she told Reuters. “It’s a clear message that we need better ways to pick up the virus.”  Scientists are now more convinced than ever that a two-pronged approach which aims to firmly suppress the virus while bolstering the immune system provides the best way forward. “We need to attack in two ways - reduce the virus to very low levels and also to boost the immune response. We can’t do one without the other,” said Lewin. “So we still have to think of other creative ways to control HIV. And it’s still early days... before we can say which approach is likely to be the winner.” Claim: Relapse of 'cured' HIV patients spurs AIDS science on.

Answer: Scientists seeking a cure for AIDS say they have been inspired, not crushed, by a major setback in which two HIV positive patients believed to have been cured found the virus re-invading their bodies once more.


Question: Paragraph: The Supreme Judicial Court said MIT cannot be blamed for the death of 25-year-old Han Nguyen, who jumped from the top of a campus building minutes after a professor confronted him about an offensive email. But it found that schools can be liable if they fail to act after they become aware that a student has attempted suicide while enrolled, or shortly before entering, or learn that the student had threatened to commit suicide. Gary Pavela, a consultant on law and policy issues in higher education, said he’s unaware of another state appellate court that has explicitly found that universities have a duty to prevent suicide in limited cases and defines those circumstances. “This will be very newsworthy to colleges around the country,” said Pavela, who has written a book about the legal questions surrounding student suicides. Jeffrey Beeler, an attorney for Nguyen’s estate, said they were disappointed the court sided with MIT, but believe its ruling will nonetheless “save student lives going forward.” An MIT spokeswoman said in a statement that Nguyen’s death was a tragedy and students’ well-being is of “paramount importance to the school.” Spokeswoman Kimberly Allen said the school already offers a “robust network” of services for students and “continually considers ways to enhance those resources.” The court noted that Nguyen never told anyone at MIT that he planned to kill himself or tried to kill himself while enrolled at the school. Furthermore, he was living off campus instead of a dormitory under “daily observation,” the court said. But the judges said schools must take “reasonable measures” to help students they know have attempted suicide while at the school or have threatened to kill themselves. That would include initiating a suicide prevention protocol, getting the student in the care of a medical professional, or contacting police, fire or emergency medical personnel. “It requires the school to really have a lot of information that the suicide is likely and the reasonable measures that the school needs to take are not extremely onerous,” said Naomi Shatz, an attorney who’s not involved in the case. A group of 18 colleges and universities — including Harvard University and Boston College — told the court that holding MIT responsible for Nguyen’s death would have far-reaching consequences by causing officials with no medical expertise to overreact to concerns out of fear of liability. Nguyen’s professors shared concerns about his mental health in the months leading up to his death, and one encouraged his colleagues to pass him or they might have “blood on their hands.” In a telephone call 11 minutes before he killed himself, a professor “read him the riot act” over an email Nguyen sent to another MIT official that they believed was inappropriate, court records said. The family said that the school should have known that “mishandling this fragile student” would result in his suicide. But MIT said the school wasn’t aware of the severity of his condition, noting that he was treated by outside professionals and refused on-campus resources. None of the professionals who treated Nguyen while he was at MIT believed he was an imminent risk of killing himself, the school said. ___ Follow Alanna Durkin Richer at http://twitter.com/aedurkinricher . Read more of her work at http://bit.ly/2hIhzDb . Claim: Court says schools can be liable for suicides but clears MIT.

Answer: Schools can be held liable for student suicides in certain circumstances, Massachusetts’ highest court said Monday in a ruling that also cleared the Massachusetts Institute of Technology of responsibility for the death of a graduate student who killed himself on campus in 2009.


Question: Paragraph: "The story states that US sales for the product hit $99 million in 2008. But it never explained the cost to the individual. The study ""found no effect,"" the story states succinctly. The story said the researchers found the product to be safe. But it could have mentioned that the National Center for Complementary & Alternative Medicine states ""Side effects of ginkgo may include headache, nausea, gastrointestinal upset, diarrhea, dizziness, or allergic skin reactions. More severe allergic reactions have occasionally been reported."" Although the discussion was brief, it did refer to the study as ""properly designed"" and ""placebo controlled."" There was no disease-mongering of dementia or cognitive decline. 3 short quotes with different perspectives, presented in balance. In a story based on a study that pokes holes in some peoples’ beliefs about a product to prevent cognitive decline, there could have been at least one line about other research into cognitive decline. The widespread use of the product is clear in the story. The story states that the product has been in use for more than 500 years. We can’t be sure of the extent to which the story was influenced by a news release. it apparently did lift one quote from a news release/statement." Claim: Study: Ginkgo biloba has no effect on Alzheimer’s, dementia

Answer:
In fewer words than its HealthDay competitor (404 words vs. 740), this story did a slightly better job on providing context and balance. Americans spend about $100 million a year on this stuff.